Wealthspire Advisors (Maryland)’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$1.68M Buy
4,273
+107
+3% +$39.6K 0.06% 145
2020
Q2
$1.38M Buy
4,166
+51
+1% +$14.8K 0.1% 126
2020
Q1
$997K Buy
4,115
+2,079
+102% +$543K 0.09% 134
2019
Q4
$532K Buy
2,036
+76
+4% +$20K 0.04% 273
2019
Q3
$533K Sell
1,960
-12
-0.6% -$3.34K 0.04% 251
2019
Q2
$543K Buy
1,972
+3
+0.2% +$739 0.04% 243
2019
Q1
$440K Sell
1,969
-31
-2% -$6.4K 0.03% 273
2018
Q4
$372K Buy
2,000
+75
+4% +$15.4K 0.03% 277
2018
Q3
$481K Buy
1,925
+7
+0.4% +$1.7K 0.04% 255
2018
Q2
$418K Sell
1,918
-34
-2% -$7.01K 0.04% 277
2018
Q1
$374K Buy
1,952
+24
+1% +$4.43K 0.04% 309
2017
Q4
$302K Buy
1,928
+1,235
+178% +$194K 0.03% 366
2017
Q3
$108K Buy
693
+32
+5% +$5.06K 0.01% 677
2017
Q2
$107K Sell
661
-109
-14% -$17.7K 0.01% 674
2017
Q1
$119K Buy
770
+17
+2% +$2.34K 0.02% 537
2016
Q4
$88K Buy
753
+18
+2% +$2.05K 0.01% 619
2016
Q3
$83K Buy
735
+30
+4% +$3.16K 0.01% 634
2016
Q2
$65K Sell
705
-32
-4% -$2.75K 0.01% 660
2016
Q1
$58K Sell
737
-77
-9% -$5.54K 0.01% 664
2015
Q4
$59K Buy
+814
New +$58.1K 0.01% 670

Other funds holding IDXX

Wealthspire Advisors (Maryland)'s IDXX Position: Q3 2020 in Review

Wealthspire Advisors (Maryland) increased its Idexx Laboratories (IDXX) stake by 2.6% in Q3 2020, buying an estimated $39.6K and bringing the position to 4,273 shares worth $1.68M. The position accounts for 0.06% of the portfolio, ranked #145.

Wealthspire Advisors (Maryland) first reported a position in IDXX in Q4 2015 and has held it in 20 quarters since. 846 funds tracked by Wall St. Rank hold IDXX as of Q3 2020.

  • Wealthspire Advisors (Maryland) held 4,273 shares of Idexx Laboratories worth $1.68M as of Q3 2020.
  • Wealthspire Advisors (Maryland) bought 107 Idexx Laboratories shares in Q3 2020, an estimated $39.6K.
  • Idexx Laboratories made up 0.06% of Wealthspire Advisors (Maryland)'s portfolio in Q3 2020, its #145 holding.
  • Wealthspire Advisors (Maryland) first reported a position in Idexx Laboratories in Q4 2015 and has held it in 20 quarters since.
  • 846 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2020.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q3 2020, filed 13 Nov 2020.